HUP0000795A2 - Budeszonidot tartalmazó, aeroszol formájú gyógyszerkészítmény - Google Patents

Budeszonidot tartalmazó, aeroszol formájú gyógyszerkészítmény

Info

Publication number
HUP0000795A2
HUP0000795A2 HU0000795A HUP0000795A HUP0000795A2 HU P0000795 A2 HUP0000795 A2 HU P0000795A2 HU 0000795 A HU0000795 A HU 0000795A HU P0000795 A HUP0000795 A HU P0000795A HU P0000795 A2 HUP0000795 A2 HU P0000795A2
Authority
HU
Hungary
Prior art keywords
budesonide
aerosol formulations
medicinal aerosol
hfa
weight
Prior art date
Application number
HU0000795A
Other languages
English (en)
Inventor
Nayna Govind
Philip A. Jinks
Danna L. Ross
Gary H. Ward
Original Assignee
Minnesota Mining And Manufacturing Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10800599&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0000795(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining And Manufacturing Co. filed Critical Minnesota Mining And Manufacturing Co.
Publication of HUP0000795A2 publication Critical patent/HUP0000795A2/hu
Publication of HUP0000795A3 publication Critical patent/HUP0000795A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány szerinti készítmény szemcsés bűdeszőnid szűszpenzióját,HFA 134a, HFA 227 és ezek elegye közül megválasztőtt hidrőflűőr-alkánhajtóanyagőt, és adőtt esetben egy vagy több (i) őlajsav, szőrbitán-őleát és lecitin közül megválasztőtt felületaktív anyagőt, és (ii) akészítmény tömegére vőnatkőztatva legfeljebb 2,5 tömeg% etanőlttartalmaz. A találmány kiterjed a hajtóanyagők alkalmazásárabűdeszőnid szemcsék szűszpendálására. ŕ
HU0000795A 1996-09-27 1997-09-23 Medicinal aerosol formulations comprising budesonide HUP0000795A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9620187.6A GB9620187D0 (en) 1996-09-27 1996-09-27 Medicinal aerosol formulations

Publications (2)

Publication Number Publication Date
HUP0000795A2 true HUP0000795A2 (hu) 2000-08-28
HUP0000795A3 HUP0000795A3 (en) 2000-09-28

Family

ID=10800599

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000795A HUP0000795A3 (en) 1996-09-27 1997-09-23 Medicinal aerosol formulations comprising budesonide

Country Status (21)

Country Link
EP (1) EP0932397B2 (hu)
JP (1) JP2001501209A (hu)
KR (1) KR20000048646A (hu)
AR (1) AR009370A1 (hu)
AT (1) ATE320246T1 (hu)
AU (1) AU732985B2 (hu)
BR (1) BR9712125A (hu)
CA (1) CA2266431A1 (hu)
CZ (1) CZ102799A3 (hu)
DE (1) DE69735497T2 (hu)
ES (1) ES2259447T3 (hu)
GB (1) GB9620187D0 (hu)
HU (1) HUP0000795A3 (hu)
ID (1) ID22523A (hu)
MY (1) MY130946A (hu)
NO (1) NO991407D0 (hu)
PL (1) PL332422A1 (hu)
PT (1) PT932397E (hu)
SK (1) SK38399A3 (hu)
WO (1) WO1998013031A2 (hu)
ZA (1) ZA978303B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863910A (en) * 1996-01-12 1999-01-26 Bolonick; Joel Treatment of chronic inflammatory disorders of the gastrointestinal tract
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
SK286694B6 (sk) 2000-05-22 2009-03-05 Chiesi Farmaceutici S.P.A. Aerosólový farmaceutický prostriedok
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0311701D0 (en) * 2003-05-21 2003-06-25 Karib Kemi Pharm Liited Improved metered dose inhaler product
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1949891A1 (en) * 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
WO2006040598A2 (en) * 2004-10-12 2006-04-20 Generics (Uk) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
ES2259915B1 (es) * 2005-03-15 2007-12-16 Laboratorio Aldo-Union, S.A. Nueva formulacion estable de aerosoles en suspension y procedimiento de obtencion.
TW201010708A (en) * 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid
CN103655473A (zh) * 2011-10-27 2014-03-26 江苏长风药业有限公司 以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN102362859A (zh) * 2011-10-27 2012-02-29 江阴长风医药科技有限公司 以氢氟烷烃为抛射剂的布地奈德气雾剂制剂
CN109646400A (zh) * 2018-12-25 2019-04-19 上海信谊百路达药业有限公司 一种布地奈德吸入气雾剂及其制备方法
CN112891328A (zh) * 2021-04-12 2021-06-04 上海方予健康医药科技有限公司 一种吸入用布地奈德混悬液的制备方法
CN113768906B (zh) * 2021-10-25 2023-05-09 上海方予健康医药科技有限公司 新型糖皮质激素吸入气雾剂及药物组件

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) † 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5136107A (en) * 1990-06-04 1992-08-04 Ethyl Corporation Process for halogenating aromatic compounds
EP0504112A3 (en) † 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ATE204743T1 (de) † 1991-12-18 2001-09-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
DE4230876A1 (de) † 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
US5569450A (en) * 1993-03-17 1996-10-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
DE4322703A1 (de) * 1993-07-08 1995-01-12 Asta Medica Ag Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäureestern als Suspensionsstabilisatoren und Ventilschmiermittel
TW283164B (hu) * 1993-09-24 1996-08-11 Du Pont
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9425160D0 (en) † 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
MX9704550A (es) * 1994-12-22 1997-10-31 Astra Ab Formulaciones de medicamentos en aerosol.

Also Published As

Publication number Publication date
JP2001501209A (ja) 2001-01-30
HUP0000795A3 (en) 2000-09-28
GB9620187D0 (en) 1996-11-13
DE69735497D1 (de) 2006-05-11
CA2266431A1 (en) 1998-04-02
NO991407L (no) 1999-03-23
KR20000048646A (ko) 2000-07-25
SK38399A3 (en) 1999-09-10
ID22523A (id) 1999-10-28
MY130946A (en) 2007-07-31
CZ102799A3 (cs) 1999-07-14
NO991407D0 (no) 1999-03-23
PT932397E (pt) 2006-07-31
AU732985B2 (en) 2001-05-03
ATE320246T1 (de) 2006-04-15
AR009370A1 (es) 2000-04-12
AU4492697A (en) 1998-04-17
WO1998013031A2 (en) 1998-04-02
EP0932397B2 (en) 2014-04-02
WO1998013031A3 (en) 1998-08-27
PL332422A1 (en) 1999-09-13
DE69735497T2 (de) 2006-08-24
BR9712125A (pt) 1999-08-31
ZA978303B (en) 1999-03-15
EP0932397B1 (en) 2006-03-15
EP0932397A2 (en) 1999-08-04
ES2259447T3 (es) 2006-10-01

Similar Documents

Publication Publication Date Title
HUP0000795A2 (hu) Budeszonidot tartalmazó, aeroszol formájú gyógyszerkészítmény
CA2178473A1 (en) Flunisolide aerosol formulations
DK1169019T3 (da) Farmaceutisk aerosolformulering
CA2094266A1 (fr) Formulations
NO307282B1 (no) Trykkgassforpakninger under anvendelse av polyoksyetylenglyceryl-oleater, samt fremgangsmåte for fremstilling av slike trykkgassforpakninger
DE69218455D1 (de) Aerosolzusammensetzungen für arzneimittelsuspensionen
FI962478A0 (fi) Uusia vaahtoihin, etenkin rektaalisiin vaahtoihin tarkoitettuja koostumuksia ja näistä valmistettuja vaahtoja
PT96639A (pt) Processo para a preparacao de uma composicao propulsora contendo hidro-fluoro-carbonetos
NO990454L (no) Aerosol-materiale
ATE197124T1 (de) Wirkstoffe und gas enthaltende mikropartikel
AP2000001961A0 (en) Pharmaceutical aerosol formulation.
DE69231992D1 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
IL153726A0 (en) Novel aerosol formulation containing a polar fluorinated molecule
HUP0000841A2 (hu) Budesonidot tartalmazó, 0,28-0,38 g/ml szórósűrűségű, új inhalációs gyógyszerforma és eljárás előállítására
MY117377A (en) Chlorofluorocarbon-free mometasone furote aerosol formulations
MX9707238A (es) Formulaciones en aerosol de butixocort.
ECSP972240A (es) Formulaciones en aerosol de furoato de mometasona sin clorofluorocarburos